Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004924229 | SCV005593918 | uncertain significance | not specified | 2024-08-05 | criteria provided, single submitter | clinical testing | The p.L100M variant (also known as c.298C>A), located in coding exon 1 of the GALNT12 gene, results from a C to A substitution at nucleotide position 298. The leucine at codon 100 is replaced by methionine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. |